Cargando…

Model composition through model reduction: a combined model of CD95 and NF-κB signaling pathways

BACKGROUND: Many mathematical models characterizing mechanisms of cell fate decisions have been constructed recently. Their further study may be impossible without development of methods of model composition, which is complicated by the fact that several models describing the same processes could us...

Descripción completa

Detalles Bibliográficos
Autores principales: Kutumova, Elena, Zinovyev, Andrei, Sharipov, Ruslan, Kolpakov, Fedor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626841/
https://www.ncbi.nlm.nih.gov/pubmed/23409788
http://dx.doi.org/10.1186/1752-0509-7-13
_version_ 1782266253738508288
author Kutumova, Elena
Zinovyev, Andrei
Sharipov, Ruslan
Kolpakov, Fedor
author_facet Kutumova, Elena
Zinovyev, Andrei
Sharipov, Ruslan
Kolpakov, Fedor
author_sort Kutumova, Elena
collection PubMed
description BACKGROUND: Many mathematical models characterizing mechanisms of cell fate decisions have been constructed recently. Their further study may be impossible without development of methods of model composition, which is complicated by the fact that several models describing the same processes could use different reaction chains or incomparable sets of parameters. Detailed models not supported by sufficient volume of experimental data suffer from non-unique choice of parameter values, non-reproducible results, and difficulty of analysis. Thus, it is necessary to reduce existing models to identify key elements determining their dynamics, and it is also required to design the methods allowing us to combine them. RESULTS: Here we propose a new approach to model composition, based on reducing several models to the same level of complexity and subsequent combining them together. Firstly, we suggest a set of model reduction tools that can be systematically applied to a given model. Secondly, we suggest a notion of a minimal complexity model. This model is the simplest one that can be obtained from the original model using these tools and still able to approximate experimental data. Thirdly, we propose a strategy for composing the reduced models together. Connection with the detailed model is preserved, which can be advantageous in some applications. A toolbox for model reduction and composition has been implemented as part of the BioUML software and tested on the example of integrating two previously published models of the CD95 (APO-1/Fas) signaling pathways. We show that the reduced models lead to the same dynamical behavior of observable species and the same predictions as in the precursor models. The composite model is able to recapitulate several experimental datasets which were used by the authors of the original models to calibrate them separately, but also has new dynamical properties. CONCLUSION: Model complexity should be comparable to the complexity of the data used to train the model. Systematic application of model reduction methods allows implementing this modeling principle and finding models of minimal complexity compatible with the data. Combining such models is much easier than of precursor models and leads to new model properties and predictions.
format Online
Article
Text
id pubmed-3626841
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36268412013-04-24 Model composition through model reduction: a combined model of CD95 and NF-κB signaling pathways Kutumova, Elena Zinovyev, Andrei Sharipov, Ruslan Kolpakov, Fedor BMC Syst Biol Research Article BACKGROUND: Many mathematical models characterizing mechanisms of cell fate decisions have been constructed recently. Their further study may be impossible without development of methods of model composition, which is complicated by the fact that several models describing the same processes could use different reaction chains or incomparable sets of parameters. Detailed models not supported by sufficient volume of experimental data suffer from non-unique choice of parameter values, non-reproducible results, and difficulty of analysis. Thus, it is necessary to reduce existing models to identify key elements determining their dynamics, and it is also required to design the methods allowing us to combine them. RESULTS: Here we propose a new approach to model composition, based on reducing several models to the same level of complexity and subsequent combining them together. Firstly, we suggest a set of model reduction tools that can be systematically applied to a given model. Secondly, we suggest a notion of a minimal complexity model. This model is the simplest one that can be obtained from the original model using these tools and still able to approximate experimental data. Thirdly, we propose a strategy for composing the reduced models together. Connection with the detailed model is preserved, which can be advantageous in some applications. A toolbox for model reduction and composition has been implemented as part of the BioUML software and tested on the example of integrating two previously published models of the CD95 (APO-1/Fas) signaling pathways. We show that the reduced models lead to the same dynamical behavior of observable species and the same predictions as in the precursor models. The composite model is able to recapitulate several experimental datasets which were used by the authors of the original models to calibrate them separately, but also has new dynamical properties. CONCLUSION: Model complexity should be comparable to the complexity of the data used to train the model. Systematic application of model reduction methods allows implementing this modeling principle and finding models of minimal complexity compatible with the data. Combining such models is much easier than of precursor models and leads to new model properties and predictions. BioMed Central 2013-02-15 /pmc/articles/PMC3626841/ /pubmed/23409788 http://dx.doi.org/10.1186/1752-0509-7-13 Text en Copyright © 2013 Kutumova et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kutumova, Elena
Zinovyev, Andrei
Sharipov, Ruslan
Kolpakov, Fedor
Model composition through model reduction: a combined model of CD95 and NF-κB signaling pathways
title Model composition through model reduction: a combined model of CD95 and NF-κB signaling pathways
title_full Model composition through model reduction: a combined model of CD95 and NF-κB signaling pathways
title_fullStr Model composition through model reduction: a combined model of CD95 and NF-κB signaling pathways
title_full_unstemmed Model composition through model reduction: a combined model of CD95 and NF-κB signaling pathways
title_short Model composition through model reduction: a combined model of CD95 and NF-κB signaling pathways
title_sort model composition through model reduction: a combined model of cd95 and nf-κb signaling pathways
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626841/
https://www.ncbi.nlm.nih.gov/pubmed/23409788
http://dx.doi.org/10.1186/1752-0509-7-13
work_keys_str_mv AT kutumovaelena modelcompositionthroughmodelreductionacombinedmodelofcd95andnfkbsignalingpathways
AT zinovyevandrei modelcompositionthroughmodelreductionacombinedmodelofcd95andnfkbsignalingpathways
AT sharipovruslan modelcompositionthroughmodelreductionacombinedmodelofcd95andnfkbsignalingpathways
AT kolpakovfedor modelcompositionthroughmodelreductionacombinedmodelofcd95andnfkbsignalingpathways